Vext Science Inc
VV5
Company Profile
Business description
Vext Science Inc provides management, advisory, cultivation, and dispensary services to entities in the medical cannabis field. The company’s expertise spans from cultivation through to retail operations. Its revenue sources include management fees, professional services, product sales, equipment leasing and property leasing. The company’s operations consist of a single operating segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the United States.
Contact
4152 N. 39th Avenue, Admin
PhoenixAZ85019
USAT: +1 844 211-3725
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
173
Stocks News & Analysis
stocks
Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?
Amid robust demand for semis, watch for any impact of in-house built chips and whether the supply chain is on track.
stocks
Higher interest rates boost earnings for ASX real estate platform
Interest rates are driving a spike in property listings.
stocks
After earnings, is Palantir a buy, a sell, or fairly valued?
With uncertainty regarding its total addressable market and competitive threats, here’s what we think of Palantir stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,880.70 | 7.70 | 0.09% |
| CAC 40 | 7,982.15 | 2.23 | 0.03% |
| DAX 40 | 24,087.02 | 132.09 | 0.55% |
| Dow JONES (US) | 49,505.08 | 255.48 | -0.51% |
| FTSE 100 | 10,301.25 | 35.93 | 0.35% |
| HKSE | 26,388.44 | 40.53 | 0.15% |
| NASDAQ | 26,122.41 | 34.21 | 0.13% |
| Nikkei 225 | 63,272.11 | 529.54 | 0.84% |
| NZX 50 Index | 13,063.06 | 17.27 | -0.13% |
| S&P 500 | 7,391.18 | 9.78 | -0.13% |
| S&P/ASX 200 | 8,630.40 | 0.60 | -0.01% |
| SSE Composite Index | 4,242.57 | 28.08 | 0.67% |